Search - tctmd.com

Displaying 21 - 40 of 43

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Embedding "Shared Decision-making" as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Megan Coylewright

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Presenter: Susheel K. Kodali

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Presenter: Steven F. Bolling

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

Presenter: Randolph P. Martin, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure III: The MANTA Device

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure II: The InSeal Device

Presenter: Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Large Hole Transfemoral Closure I: The PerQseal Device

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR Device Selection and CT Sizing for Bicuspid Aortic Valves

Presenter: John C Laschinger, Mathew Williams, Didier Tchetche

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

When and How to Use Transcatheter Devices for PVL Closure After TAVR

Presenter: Colin M. Barker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Presenter: Anthony N. DeMaria, Allan Schwartz, Scott Lim

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cedars-Sinai Medical Center (USA)

Presenter: Tarun Chakravarty

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Erasmus University (The Netherlands)

Presenter: Nicolas M. Van Mieghem

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Ulm University (Germany)

Presenter: Julia Seeger

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Presenter: Eberhard Grube, Tamim Nazif, Hemal Gada

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Presenter: Eberhard Grube, Tamim Nazif, Chetan P. Huded

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

Presenter: Eberhard Grube, Tamim Nazif, Alexandra J. Lansky

June 21, 2018

Video

SHDS 2018: Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

June 26, 2018

Advertisement

Embedding "Shared Decision-making" as a Fundamental Component of Clinical Research, Regulatory Device Approval, and Clinical Practice

Other Transcatheter TR Device Therapies Coaptation Spacers and Valve Replacement - Should Be Added to the Armamentarium

Transcatheter Mitral Annuloplasty Devices Will Be the "Centerpiece" in the Future

Exploring the Volume-Outcome Relationship With TAVR: Influences of New Devices and Crowd Learning

Large Hole Transfemoral Closure III: The MANTA Device

Large Hole Transfemoral Closure II: The InSeal Device

Large Hole Transfemoral Closure I: The PerQseal Device

TAVR Device Selection and CT Sizing for Bicuspid Aortic Valves

When and How to Use Transcatheter Devices for PVL Closure After TAVR

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Special Considerations for Transcatheter Therapies in Patients With Functional MR and TR (Access, Imaging, and Device Selection)

Cedars-Sinai Medical Center (USA)

Erasmus University (The Netherlands)

Ulm University (Germany)

Cost-effectiveness of Cerebral Protection During TAVR: Can We Justify Systematic Use?

Strokes After Transfemoral TAVR vs SAVR: A Propensity-Matched Analysis From the PARTNER Trial

Strokes After TAVR (and SAVR): Incidence in the "Modern Era" and Key Messages From NeuroARC

SHDS 2018: Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device: The SAFE MANTA Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content